Literature DB >> 12869306

Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis.

Zhaorui Lian1, Jie Liu, Li Li, Xianxing Li, N Lale Satiroglu Tufan, Marcy Clayton, Meng-Chao Wu, Hong-Yang Wang, Patrick Arbuthnot, Michael Kew, Mark A Feitelson.   

Abstract

Hepatitis B x antigen (HB x Ag) is a trans-activating protein that may be involved in hepatocarcinogenesis, although few natural effectors of HB x Ag that participate in this process have been identified. To identify additional effectors, whole cell RNA isolated from HB x Ag-positive and HB x Ag-negative HepG2 cells were compared by polymerase chain reaction select cDNA subtraction, and one clone, upregulated gene, clone 11 (URG11), was chosen for further characterization. Elevated levels of URG11 mRNA and protein were observed in HB x Ag-positive compared to HB x Ag-negative HepG2 cells. Costaining was observed in infected liver (P < 0.01). URG11 stimulated cell growth in culture (P < 0.01), anchorage-independent growth in soft agar (P < 0.001), and accelerated tumor formation (P < 0.01), and yielded larger tumors (P < 0.02) in SCID mice injected subcutaneously with HepG2 cells. These data suggest that URG11 is a natural effector of HB x Ag that may promote the development of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869306      PMCID: PMC1502406          DOI: 10.1016/S1476-5586(03)80055-6

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  53 in total

1.  Crystal structure of the C-type lectin-like domain from the human hematopoietic cell receptor CD69.

Authors:  A S Llera; F Viedma; F Sánchez-Madrid; J Tormo
Journal:  J Biol Chem       Date:  2000-10-17       Impact factor: 5.157

Review 2.  The modular architecture of a new family of growth regulators related to connective tissue growth factor.

Authors:  P Bork
Journal:  FEBS Lett       Date:  1993-07-26       Impact factor: 4.124

3.  The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis.

Authors:  Z Lian; J Pan; J Liu; S Zhang; M Zhu; P Arbuthnot; M Kew; M A Feitelson
Journal:  Oncogene       Date:  1999-03-04       Impact factor: 9.867

4.  Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors.

Authors:  E Seto; P J Mitchell; T S Yen
Journal:  Nature       Date:  1990-03-01       Impact factor: 49.962

Review 5.  Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.

Authors:  M A Feitelson; L X Duan
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

6.  Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway.

Authors:  P Chirillo; M Falco; P L Puri; M Artini; C Balsano; M Levrero; G Natoli
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.

Authors:  Katrina Nicholes; Susan Guillet; Elizabeth Tomlinson; Kenneth Hillan; Barbara Wright; Gretchen D Frantz; Thinh A Pham; Lisa Dillard-Telm; Siao Ping Tsai; Jean-Philippe Stephan; Jeremy Stinson; Timothy Stewart; Dorothy M French
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

8.  Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C.

Authors:  R Lucito; R J Schneider
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma.

Authors:  P Paterlini; K Poussin; M Kew; D Franco; C Brechot
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

10.  Characteristics of woodchuck hepatitis X-antigen in the livers and sera from infected animals.

Authors:  M A Feitelson; L Lega; L X Duan; M Clayton
Journal:  J Hepatol       Date:  1993       Impact factor: 25.083

View more
  10 in total

Review 1.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

2.  The regulation of proteins associated with the cytoskeleton by hepatitis B virus X protein during hepatocarcinogenesis.

Authors:  Fanyun Kong; Hongjuan You; Renxian Tang; Kuiyang Zheng
Journal:  Oncol Lett       Date:  2017-02-22       Impact factor: 2.967

3.  HBx interacted with Smad4 to deprive activin a growth inhibition function in hepatocyte HL7702 on CRM1 manner.

Authors:  Ying Shi; Haipeng Zhang; Zhu Han; Xuguang Mi; Wenyan Zhang; Mingyu Lv
Journal:  Tumour Biol       Date:  2015-10-08

4.  VWCE as a potential biomarker associated with immune infiltrates in breast cancer.

Authors:  Qin Huo; Zhenwei Li; Siqi Chen; Juan Wang; Jiaying Li; Ni Xie
Journal:  Cancer Cell Int       Date:  2021-05-21       Impact factor: 5.722

5.  Role of miR-148a in hepatitis B associated hepatocellular carcinoma.

Authors:  Ke Yuan; Zhaorui Lian; Bill Sun; Marcia M Clayton; Irene O L Ng; Mark A Feitelson
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

6.  URG11 Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion.

Authors:  Bin Pan; Yunlin Ye; Haiping Liu; Jianli Zhen; Hongmei Zhou; Yutong Li; Lijun Qu; Youke Wu; Chuanrong Zeng; Weifeng Zhong
Journal:  Biomed Res Int       Date:  2018-05-31       Impact factor: 3.411

7.  URG11 promotes proliferation and induced apoptosis of LNCaP cells.

Authors:  Chenmin Sun; Guangming Zhang; Shujie Cheng; Haining Qian; Dong Li; Min Liu
Journal:  Int J Mol Med       Date:  2019-03-05       Impact factor: 4.101

8.  View and review on viral oncology research.

Authors:  Valeria Bergonzini; Cristiano Salata; Arianna Calistri; Cristina Parolin; Giorgio Palù
Journal:  Infect Agent Cancer       Date:  2010-05-24       Impact factor: 2.965

9.  URG11 promotes gastric cancer growth and invasion by activation of beta-catenin signalling pathway.

Authors:  Rui Du; Lin Xia; Shiren Sun; Zhaorui Lian; Xue Zou; Juan Gao; Huahong Xie; Rui Fan; Jiugang Song; Xiaohua Li; Jie Liu; Daiming Fan
Journal:  J Cell Mol Med       Date:  2008-12-24       Impact factor: 5.310

10.  VWCE Functions as a Tumor Suppressor in Breast Cancer Cells.

Authors:  Dan Zhang; Lili Wan; Fan Yang; Wenlan Liu; Litao Liu; Shengnan He; Ni Xie
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.